YARROW BIOSCIENCE, INC. Increase Decrease In Operating Lease Liability
YARROW BIOSCIENCE, INC. (YARW) reported Increase Decrease In Operating Lease Liability of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-13
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for the quarter ending 2026-06-30 was $0.00.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for the quarter ending 2026-03-31 was $0.00.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$37.00K.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$37.00K.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for fiscal 2023 was $214.00K.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for fiscal 2022 was -$349.00K.
- YARROW BIOSCIENCE, INC. increase decrease in operating lease liability for fiscal 2021 was -$1.21M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | $0.00 10-Q · filed 2026-08-13 | ||
| 2026-03-31 | $0.00 S-4/A · filed 2026-06-03 | |||
| 2025-12-31 | -$99.00K S-4/A · filed 2026-06-03 | |||
| 2025-06-30 | -$37.00K derived: 10-Q 6 month − S-4/A 3 month · filed 2026-08-13 | -$74.00K 10-Q · filed 2026-08-13 | -$97.00K derived: sum of 3 quarters · filed 2026-08-13 | -$119.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | -$37.00K S-4/A · filed 2026-06-03 | -$60.00K derived: sum of 2 quarters · filed 2026-06-03 | -$82.00K derived: sum of 3 quarters · filed 2026-06-03 | -$117.00K derived: sum of 4 quarters · filed 2026-06-03 |
| 2024-12-31 | -$23.00K derived: S-4/A 12 month − 10-Q 9 month · filed 2026-06-03 | -$45.00K derived: sum of 2 quarters · filed 2026-06-03 | -$80.00K derived: sum of 3 quarters · filed 2026-06-03 | -$114.00K S-4/A · filed 2026-06-03 |
| 2024-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$57.00K derived: sum of 2 quarters · filed 2025-08-14 | -$91.00K 10-Q · filed 2024-11-07 | $123.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$69.00K 10-Q · filed 2025-08-14 | $145.00K derived: sum of 3 quarters · filed 2025-08-14 | $145.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | -$34.00K 10-Q · filed 2025-05-08 | $180.00K derived: sum of 2 quarters · filed 2025-05-08 | $180.00K derived: sum of 3 quarters · filed 2025-05-08 | $180.00K derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | $214.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $214.00K derived: sum of 2 quarters · filed 2025-03-06 | $214.00K derived: sum of 3 quarters · filed 2025-03-06 | $214.00K 10-K · filed 2025-03-06 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $0.00 10-Q · filed 2024-08-14 | $0.00 derived: sum of 3 quarters · filed 2024-08-14 | -$31.00K derived: sum of 4 quarters · filed 2024-08-14 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-05-09 | -$31.00K derived: sum of 3 quarters · filed 2024-05-09 | -$117.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-01 | -$31.00K derived: sum of 2 quarters · filed 2024-03-01 | -$117.00K derived: sum of 3 quarters · filed 2024-03-01 | -$349.00K 10-K · filed 2024-03-01 |
| 2022-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$117.00K derived: sum of 2 quarters · filed 2023-11-13 | -$349.00K 10-Q · filed 2023-11-13 | -$1.55M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$318.00K 10-Q · filed 2023-08-14 | -$1.52M derived: sum of 3 quarters · filed 2023-08-14 | -$1.53M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | -$232.00K 10-Q · filed 2023-05-11 | -$1.44M derived: sum of 2 quarters · filed 2023-05-11 | -$1.44M derived: sum of 3 quarters · filed 2023-05-11 | -$1.44M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | -$1.21M derived: sum of 2 quarters · filed 2023-03-14 | -$1.21M derived: sum of 3 quarters · filed 2023-03-14 | -$1.21M 10-K · filed 2023-03-14 |
| 2021-09-30 | -$6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | -$6.00K derived: sum of 2 quarters · filed 2022-11-14 | -$6.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |